Search results
Results from the WOW.Com Content Network
The effects of inhalant use are also modified by the combined use of inhalants and alcohol or other drugs. In the short term, many users experience headaches, nausea and vomiting, slurred speech, loss of motor coordination, and wheezing. A characteristic "glue sniffer's rash" around the nose and mouth is sometimes seen after prolonged use.
The number of 12- to 17-year-old American adolescents using inhalants has declined ... of seeking more potent drugs,” Pizon said. The short-term effects, which can be immediate and last a few ...
Nitrous oxide, as medical gas supply, is an inhaled gas used as pain medication, and is typically administered with 50% oxygen mix. It is often used together with other medications for anesthesia. [2] Common uses include during childbirth, following trauma, and as part of end-of-life care. [2]
Common side effects of inhalant use include dry mouth, cough, inflammation of the airways, [3] and shortness of breath. [8] Potentially serious side effects include urinary retention, worsening spasms of the airways, and a severe allergic reaction. [3] It appears to be safe in pregnancy and breastfeeding.
Inhalable drugs can deliver high concentrations of medication directly to the site of action, which can enhance effectiveness and minimize systemic side effects. The technology behind inhalable drugs has advanced significantly over the years, with various delivery systems available, including metered-dose inhalers (MDIs), dry powder inhalers ...
Regulators, researchers and advocates disagree about the best way to discourage use of difluoroethane, which played a role in singer Aaron Carter’s death.
Methoxyflurane, sold under the brand name Penthrox among others, is an inhaled medication primarily used to reduce pain following trauma. [5] [6] It may also be used for short episodes of pain as a result of medical procedures. [4]
The most common side effects include headache, oral candidiasis, cough, and difficulty speaking. [2] Salbutamol/budesonide was approved for medical use in the United States in January 2023. [2] [3] It is the first combination of an inhaled corticosteroid and a short-acting beta-agonist to be approved by the US Food and Drug Administration (FDA ...